These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25913754)

  • 1. Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopenia.
    Gilmore JF; Adams CD; Blum RM; Fanikos J; Anne Hirning B; Matta L
    Am J Hematol; 2015 Aug; 90(8):E143-5. PubMed ID: 25913754
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.
    Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST
    Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

  • 5. Bivalirudin for the treatment of patients with confirmed or suspected heparin-induced thrombocytopenia.
    Joseph L; Casanegra AI; Dhariwal M; Smith MA; Raju MG; Militello MA; Gomes MP; Gornik HL; Bartholomew JR
    J Thromb Haemost; 2014 Jul; 12(7):1044-53. PubMed ID: 24766902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hitting back HIT.
    Gude D
    Ann Card Anaesth; 2012; 15(2):168-9. PubMed ID: 22508216
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and effectiveness outcomes of an inpatient collaborative drug therapy management service for direct thrombin inhibitors.
    Cooper T; White CL; Taber D; Uber WE; Kokko H; Mazur J
    Am J Health Syst Pharm; 2012 Nov; 69(22):1993-8. PubMed ID: 23135566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia.
    Tsu LV; Dager WE
    Ann Pharmacother; 2011 Oct; 45(10):1185-92. PubMed ID: 21881032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes.
    Abel EE; Kane-Gill SL; Seybert AL; Kellum JA
    Am J Health Syst Pharm; 2012 Sep; 69(18):1559-67. PubMed ID: 22935938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia.
    Greinacher A
    N Engl J Med; 2015 Jul; 373(3):252-61. PubMed ID: 26176382
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment: treatment of heparin-induced thrombocytopenia.
    Smythe MA; Warkentin TE
    Ann Pharmacother; 2002 Sep; 36(9):1483-4; author reply 1484. PubMed ID: 12196076
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Hursting MJ
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia: a general review.
    Swanson JM
    J Infus Nurs; 2007; 30(4):232-40. PubMed ID: 17667079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.
    Campbell KR; Mahaffey KW; Lewis BE; Weitz JI; Berkowitz SD; Ohman EM; Califf RM
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():14F-9. PubMed ID: 11156729
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: treatment options and special considerations.
    Dager WE; Dougherty JA; Nguyen PH; Militello MA; Smythe MA
    Pharmacotherapy; 2007 Apr; 27(4):564-87. PubMed ID: 17381384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia.
    Saad RA
    N Engl J Med; 2006 Dec; 355(24):2598; author reply 2598-9. PubMed ID: 17167148
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring the direct thrombin inhibitors.
    Fritsma GA
    Clin Lab Sci; 2013; 26(1):54-7. PubMed ID: 23479838
    [No Abstract]   [Full Text] [Related]  

  • 20. Bivalirudin in off-pump coronary artery bypass graft in a patient with heparin-induced thrombocytopenia: a case report of its use.
    Audette MD; Glymph DC
    AANA J; 2015 Apr; 83(2):116-22. PubMed ID: 26016170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.